×
About 1,438 results

ALLMedicine™ Breast Biopsy Center

Research & Reviews  456 results

A Multilayered, Lesion-Embedded Ultrasound Breast Phantom with Realistic Visual and Hap...
https://doi.org/10.1016/j.ultrasmedbio.2022.03.009
Ultrasound in Medicine & Biology; Ng SY, Lin CL

May 10th, 2022 - Anthropomorphic phantoms have been used to provide residents with training in ultrasound-guided breast biopsy. However, different individuals differ in terms of the acoustic properties and stiffness of their breast tissues. The individual differen...

Evaluating the Value of Audio-guided Meditation During Breast Biopsy Procedures
https://clinicaltrials.gov/ct2/show/NCT05343975

Apr 25th, 2022 - audio-guided meditation during breast biopsy procedures questionnaires (STAI-ETAT and EN) before and after the procedure.

Intraductal Papilloma on Breast Biopsy: Upstaging Rate and Implications for Practice Gu...
https://doi.org/10.1177/00031348221082276
The American Surgeon; Jee Y, Bakht A et. al.

Apr 15th, 2022 - The recommendation for management of intraductal papilloma has not been clearly established and its surgical excision criteria remain controversial. This study determines the institutional malignancy upstage rate of benign intraductal papillomas a...

Rate of breast biopsy referrals in female BRCA mutation carriers aged 50 years or more:...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090689
Breast Cancer Research and Treatment; Pomerantz A, Tsoref D et. al.

Apr 9th, 2022 - To evaluate the total biopsy and positive biopsy rates in women at high risk of breast cancer compared to the general population. The study group consisted of 330 women with pathogenic variants (PVs) in BRCA1/2 attending the dedicated multidiscipl...

see more →

Drugs  29 results see all →

Clinicaltrials.gov  32 results

Evaluating the Value of Audio-guided Meditation During Breast Biopsy Procedures
https://clinicaltrials.gov/ct2/show/NCT05343975

Apr 25th, 2022 - audio-guided meditation during breast biopsy procedures questionnaires (STAI-ETAT and EN) before and after the procedure.

VITamin D and OmegA-3 TriaL: Effects on Mammographic Density and Breast Tissue
https://clinicaltrials.gov/ct2/show/NCT02239874

Apr 7th, 2022 - Mammographic density is one of the strongest risk factors for breast cancer. It is predictive of breast cancer risk for at least 10 years in the futue and has been suggested as a surrogate marker of breast cancer risk. Several states now mandate r...

Academic-Industrial Partnership for Translation of Acoustic Angiography
https://clinicaltrials.gov/ct2/show/NCT03544268

Apr 1st, 2022 - Increasing the sensitivity and specificity of diagnostic imaging in patients at high risk for breast cancer could provide substantial clinical benefit by improving diagnosis, preventing over-treatment, and reducing healthcare costs. Acoustic angio...

Breast Cancer BRCA1 Carriers: a Pilot Study
https://clinicaltrials.gov/ct2/show/NCT05062174

Feb 2nd, 2022 - This is a single arm, prospective, observational trial enrolling up to 10 patients within Indiana University Simon Comprehensive Cancer Center. Eligible women will be consented to undergo breast biopsy 2-6 days prior to prophylactic mastectomy and...

Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in Triple Positive Breast Cancers
https://clinicaltrials.gov/ct2/show/NCT04886531

Jan 12th, 2022 - Patient will be treated with neratinib, an aromatase inhibitor and trastuzumab for 24 weeks prior to surgery, following an initial 3 weeks of neratinib alone, aromatase inhibitor alone or the combination of neratinib and an aromatase inhibitor. A ...

see more →

News  47 results

Breast Cancer Trials Enrolling Now: Could Your Patient Benefit?
https://www.medscape.com/viewarticle/968608

Feb 16th, 2022 - A number of clinical trials in breast cancer have opened in recent months. Maybe one of your patients could benefit from being enrolled. Menopausal women at moderate risk of developing breast cancer. A phase 2 study sponsored by the National Cance...

Patient Case: Frontline Treatment Options for HER2+ mBC
https://www.onclive.com/view/patient-case-frontline-treatment-options-for-her2-mbc

Feb 2nd, 2022 - Vijayakrishna Gadi, MD, PhD: We have a little more information on this patient. We find out from the breast biopsy that she’s got 1 of these HER2 [human epidermal growth factor receptor 2]–enriched phenotypes. She’s hormone receptor–negative for e...

Dr. Blanco on the Role of Pathology in Treatment of Breast Cancer
https://www.onclive.com/view/dr-blanco-discusses-the-role-of-pathology-in-treatment-of-breast-cancer

Dec 20th, 2020 - Luis Z. Blanco Jr., MD, assistant professor of pathology, Northwestern University, discusses the role a pathologist plays in the treatment of a patient with breast cancer in an interview with OncLive during the Lynn Sage Breast Cancer Symposium. ...

Will patient rewards for lower-cost choices impact physicians?
https://www.mdedge.com/neurology/article/196674/business-medicine/will-patient-rewards-lower-cost-choices-impact-physicians?channel=39313
Gregory Twachtman

Mar 19th, 2019 - Patients will actively choose lower-cost options for certain health care services if their employers reward them for doing so. ThinkStock “In the first 12 months of the rewards program, we observed a 2.

Malpractice Case: How Careful Physicians Can Miss Vital Information
https://www.staging.medscape.com/viewarticle/903385

Dec 5th, 2018 - Medscape Editor's Key Points: When receiving test results from other clinicians, be sure to review each line to avoid overlooking details. Place all reports and addenda in a patient's chart to maintain an ongoing record of care and to avoid missed...

see more →

Patient Education  11 results see all →